The DOI matches its Crossref record; 369 of the 369 references it cites were found in a registry or an index.
Basic Mechanisms of Diabetic Heart Disease
Open accessAbstract
Diabetes mellitus predisposes affected individuals to a significant spectrum of cardiovascular complications, one of the most debilitating in terms of prognosis is heart failure. Indeed, the increasing global prevalence of diabetes mellitus and an aging population has given rise to an epidemic of diabetes mellitus–induced heart failure. Despite the significant research attention this phenomenon, termed diabetic cardiomyopathy, has received over several decades, understanding of the full spectrum of potential contributing mechanisms, and their relative contribution to this heart failure phenotype in the specific context of diabetes mellitus, has not yet been fully resolved. Key recent preclinical discoveries that comprise the current state-of-the-art understanding of the basic mechanisms of the complex phenotype, that is, the diabetic heart, form the basis of this review. Abnormalities in each of cardiac metabolism, physiological and pathophysiological signaling, and the mitochondrial compartment, in addition to oxidative stress, inflammation, myocardial cell death pathways, and neurohumoral mechanisms, are addressed. Further, the interactions between each of these contributing mechanisms and how they align to the functional, morphological, and structural impairments that characterize the diabetic heart are considered in light of the clinical context: from the disease burden, its current management in the clinic, and where the knowledge gaps remain. The need for continued interrogation of these mechanisms (both known and those yet to be identified) is essential to not only decipher the how and why of diabetes mellitus–induced heart failure but also to facilitate improved inroads into the clinical management of this pervasive clinical challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–369 of 369
Yki‐Järvinen, H., Daniels, M. C., Virkamäki, A., Mäkimattila, S., DeFronzo, R. A., & McClain, D. A. (1996) · Diabetes · doi:10.2337/diab.45.3.302 · Cited by 140
Cardiac myofibrillar ATPase activity in diabetic rats
Pierce, G. N. (1981) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(81)90296-0 · Cited by 140
Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes
Lacombe, V. A., Viatchenko‐Karpinski, S., Terentyev, D. A., Sridhar, A., Emani, S., Bonagura, J. D., Feldman, D. S., Györke, S., & Carnes, C. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00059.2007 · Cited by 140
Huynh, K., Kiriazis, H., Du, X., Love, J. E., Gray, S. P., Jandeleit-Dahm, K. A. M., McMullen, J. R., & Ritchie, R. H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.021 · Cited by 139
Self-citationExercise improves cardiac autonomic function in obesity and diabetes
Voulgari, C., Pagoni, S., Vinik, A. I., & Poirier, P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.005 · Cited by 139
Zhao, Y., Zhang, L., Qiao, Y., Zhou, X., Wu, G., Wang, L., Peng, Y., Dong, X., Huang, H., Si, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075927 · Cited by 138
The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus
Dawson, A., Morris, A. D., & Struthers, A. D. (2005) · Diabetologia · doi:10.1007/s00125-005-1896-y · Cited by 137
Jia, G., Habibi, J., DeMarco, V. G., Martinez-Lemus, L. A., Ma, L., Whaley-Connell, A. T., Aroor, A. R., Domeier, T. L., Zhu, Y., Meininger, G. A., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06015 · Cited by 137
Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity
Jaishy, B. P., Zhang, Q., Chung, H. S., Riehle, C., Soto, J. E., Jenkins, S., Abel, P., Cowart, L. A., Eyk, J. E. V., & Abel, E. D. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m055152 · Cited by 136
Self-citationCardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs
Tikellis, C., Thomas, M. C., Harcourt, B. E., Coughlan, M. T., Pete, J., Bialkowski, K., Tan, A. L. Y., Bierhaus, A., Cooper, M. E., & Forbes, J. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00024.2008 · Cited by 136
Hippisley‐Cox, J., & Coupland, C. A. C. (2016) · BMJ · doi:10.1136/bmj.i3477 · Cited by 135
Factor, S. M., Minase, T., Cho, S., Fein, F. S., Capasso, J. M., & Sonnenblick, E. H. (1984) · PubMed · Cited by 130
Pappachan, J. M., Sebastian, J., Bino, B. C., Jayaprakash, K., Vijayakumar, K., Sujathan, P., & Abas, A. L. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.064048 · Cited by 127
Wang, Q., Liu, Y., Fu, Q., Xu, B. Y., Zhang, Y., Kim, S., Tan, R., Barbagallo, F., West, T. M., Anderson, E. J., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022281 · Cited by 124
Self-citationLi, Y., Ma, J., Zhu, H., Singh, M., Hill, D. J., Greer, P. A., Arnold, J. M. O., Abel, E. D., & Peng, T. (2011) · Diabetes · doi:10.2337/db10-1333 · Cited by 123
Self-citationRickard, A. J., Morgan, J., Bienvenu, L. A., Fletcher, E. K., Cranston, G. A., Shen, J., Reichelt, M. E., Delbridge, L. M. D., & Young, M. J. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.203158 · Cited by 123
Sitagliptin Use in Patients With Diabetes and Heart Failure
Weir, D. L., McAlister, F. A., Senthilselvan, A., Minhas‐Sandhu, J. K., & Eurich, D. T. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.04.005 · Cited by 122
The Role of AGEs in Cardiovascular Disease
Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784139684 · Cited by 121
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
Feng, B., Chen, S., Chiu, J., George, B., & Chakrabarti, S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00029.2008 · Cited by 120
Bello, V. D., Talarico, L., Picano, E., Muro, C. D., Landini, L., Paterni, M., Matteucci, E., Giusti, C., & Giampietro, O. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00026-z · Cited by 120
Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats
Lopaschuk, G. D., Tahiliani, A. G., Vadlamudi, R. V. S. V., Katz, S., & McNeill, J. H. (1983) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1983.245.6.h969 · Cited by 120
Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy
Fricovsky, E. S., Suárez, J., Ihm, S., Scott, B. T., Suarez-Ramirez, J. A., Banerjee, I., Torres‐Gonzalez, M., Wang, H., Ellrott, I., Maya-Ramos, L., et al. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00548.2011 · Cited by 119
Gao, X., Liu, Y., White, D., Su, Y., Drew, B. G., Bruce, C. R., Kiriazis, H., Xu, Q., Jennings, N. L., Bobik, A., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.022 · Cited by 118
Desrois, M. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.021 · Cited by 118
Protein O-linked β-N-acetylglucosamine: A novel effector of cardiomyocyte metabolism and function
Darley-Usmar, V. M., Ball, L. E., & Chatham, J. C. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.08.009 · Cited by 116
Gray, S. P., Jha, J. C., Kennedy, K., van Bommel, E. J. M., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4215-5 · Cited by 114
Cardiomyocyte Dysfunction in Sucrose-Fed Rats Is Associated With Insulin Resistance
Dutta, K., Podolin, D. A., Davidson, M., & Davidoff, A. J. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1186 · Cited by 113
Electrical Stimulation Promotes Cardiac Differentiation of Human Induced Pluripotent Stem Cells
Hernández, D., Millard, R. E., Sivakumaran, P., Wong, R. C. B., Crombie, D. E., Hewitt, A. W., Liang, H. H., Hung, S. S. C., Pébay, A., Shepherd, R. K., et al. (2015) · Stem Cells International · doi:10.1155/2016/1718041 · Cited by 111
Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview
Shah, S. J. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9756-y · Cited by 110
Fang, C. X., Dong, F., Thomas, D. P., Ma, H., He, L., & Ren, J. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00319.2008 · Cited by 109
O-GlcNAcylation and cardiovascular disease
Wright, J. N., Collins, H. E., Wende, A. R., & Chatham, J. C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160164 · Cited by 109
Muranaka, A., Yuda, S., Tsuchihashi, K., Hashimoto, A., Nakata, T., Miura, T., Tsuzuki, M., Wakabayashi, C., Watanabe, N., & Shimamoto, K. (2008) · Echocardiography · doi:10.1111/j.1540-8175.2008.00805.x · Cited by 108
Aksnes, T. A., Kjeldsen, S. E., Rostrup, M., Omvik, P., Hua, T. A., & Julius, S. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.085654 · Cited by 107
Sharma, A., Rizky, L., Stefanovic, N., Tate, M., Ritchie, R. H., Ward, K. W., & de Haan, J. B. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0513-y · Cited by 106
Self-citationCeylan‐Isik, A. F., Kandadi, M. R., Xu, X., Hua, Y., Chicco, A. J., Ren, J. T., & Nair, S. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.002 · Cited by 105
Xing, D., Feng, W., Nöt, L. G., Miller, A. P., Zhang, Y., Chen, Y.-F., Majid-Hassan, E., Chatham, J. C., & Oparil, S. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01259.2007 · Cited by 105
The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy
Wang, S., Ding, L., Ji, H., Xu, Z., Liu, Q., & Zheng, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071037 · Cited by 103
Tikellis, C., Pickering, R. J., Tsorotes, D., Huet, O., Cooper, M. E., Jandeleit-Dahm, K. A. M., & Thomas, M. C. (2014) · Diabetes · doi:10.2337/db13-0932 · Cited by 102
Are targeted therapies for diabetic cardiomyopathy on the horizon?
Tate, M., Grieve, D., & Ritchie, R. H. (2017) · Clinical Science · doi:10.1042/cs20160491 · Cited by 102
Self-citationMyocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus
Turkbey, E. B., Backlund, J. C., GENUTH, S. M., Jain, A., Miao, C., Cleary, P. A., Lachin, J. M., Nathan, D. M., van der Geest, R. J., Soliman, E. Z., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.022327 · Cited by 101
Miller, J., Floras, J. S., Zinman, B., Skorecki, K. L., & Logan, A. G. (1996) · Clinical Science · doi:10.1042/cs0900189 · Cited by 100
Prakoso, D., Lim, S. Y., Erickson, J. R., Wallace, R. S., Lees, J. G., Tate, M., Kiriazis, H., Donner, D. G., Henstridge, D. C., Davey, J. R., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab043 · Cited by 100
Self-citationJoseph, L. C., Barca, E., Subramanyam, P., Komrowski, M., Pajvani, U., Colecraft, H. M., Hirano, M., & Morrow, J. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0145750 · Cited by 99
Chowdhry, M. F., Vohra, H. A., & Galiñanes, M. (2007) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.12.059 · Cited by 99
Heart Failure and Diabetes Mellitus: Epidemiology and Management of an Alarming Association
Solal, A. C., Beauvais, F., & Logeart, D. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.04.001 · Cited by 99
Ritchie, R. H., Love, J. E., Huynh, K., Bernardo, B. C., Henstridge, D. C., Kiriazis, H., Tham, Y. K., Sapra, G., Qin, C. X., Cemerlang, N., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2720-0 · Cited by 99
Self-citationInsulin Inhibits Cardiac Contractility by Inducing a Gi-Biased β2-Adrenergic Signaling in Hearts
Fu, Q., Xu, B. Y., Liu, Y., Parikh, D., Li, J., Li, Y., Zhang, Y., Riehle, C., Zhu, Y., Rawlings, T. A., et al. (2014) · Diabetes · doi:10.2337/db13-1763 · Cited by 97
Self-citationLoss of Cardiac Phosphoinositide 3-Kinase p110α Results in Contractile Dysfunction
Lu, Z., Jiang, Y., Wang, W., Xu, X., Mathias, R. T., Entcheva, E. G., Ballou, L. M., Cohen, I. S., & Lin, R. Z. (2009) · Circulation · doi:10.1161/circulationaha.109.873380 · Cited by 96
Tate, M., Robinson, E., Green, B. D., McDermott, B. J., & Grieve, D. J. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-015-0518-1 · Cited by 96
Hou, N., Mai, Y.-P., Qiu, X., Yuan, W., Li, Y., Luo, C.-F., Liu, Y., Zhang, G., Zhao, G., & Luo, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00998 · Cited by 96
Rpl13a small nucleolar RNAs regulate systemic glucose metabolism
Lee, J., Harris, A. N., Holley, C. L., Mahadevan, J., Pyles, K. D., Lavagnino, Z., Scherrer, D. E., Fujiwara, H., Sidhu, R., Zhang, J., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88069 · Cited by 95
Fauconnier, J., Lanner, J. T., Zhang, S., Tavi, P., Bruton, J. D., Katz, A., & Westerblad, H. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2375 · Cited by 94
Liu, X., Yang, Z., Gao, Y., Xie, L., Jiang, L., Hu, B.-Y., Diao, K., Shi, K., Xu, H., Shen, M., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0782-0 · Cited by 94
Wang, Y., Sun, W., Du, B., Miao, X., Bai, Y., Xin, Y., Tan, Y., Cui, W., Liu, B., Cui, T., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00650.2012 · Cited by 93
Kranstuber, A. L., del Rio, C. L., Biesiadecki, B. J., Hamlin, R. L., Ottobre, J. S., Györke, S., & Lacombe, V. A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00292 · Cited by 92
Jadhav, A., Tiwari, S., Lee, P. C., & Ndisang, J. F. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.200808 · Cited by 91
Impaired Coronary Flow Reserve in NIDDM: A Possible Role for Diabetic Cardiopathy in Humans
Strauer, B. E., Motz, W., Vogt, M., & Schwartzkopff, B. (1997) · Diabetes · doi:10.2337/diab.46.2.s119 · Cited by 91
Srinivasan, V., Sandhya, N., Rangasamy, S., Syed, F., Mohan, V., & Balasubramanyam, M. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.05.002 · Cited by 91
Steenbergen, A. V., Balteau, M., Ginion, A., Ferté, L., Battault, S., de Meester, C., Balligand, J., Daskalopoulos, E. P., Gilon, P., Despa, F., et al. (2017) · Scientific Reports · doi:10.1038/srep41166 · Cited by 90
Pathomorphologic aspects of muscular tissue in diabetes mellitus
Fischer, V. W., Barner, H. B., & Larose, L. S. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80307-x · Cited by 88
Cathepsin K Knockout Mitigates High-Fat Diet–Induced Cardiac Hypertrophy and Contractile Dysfunction
Hua, Y., Zhang, Y., Dolence, J. M., Shi, G., Ren, J. T., & Nair, S. (2012) · Diabetes · doi:10.2337/db12-0350 · Cited by 88
Kassan, M., Choi, S. K., Galán, M., Bishop, A. J. R., Umezawa, K., Trebak, M., Belmadani, S., & Matrougui, K. (2013) · Diabetes · doi:10.2337/db12-1374 · Cited by 88
Comparative Proteomics Reveals Dysregulated Mitochondrial O-GlcNAcylation in Diabetic Hearts
Ma, J., Banerjee, P., Whelan, S. A., Liu, T., Wei, A., Ramirez‐Correa, G. A., McComb, M. E., Costello, C. E., O'Rourke, B. P., Murphy, A. M., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00250 · Cited by 88
Non‐coding RNA involvement in the pathogenesis of diabetic cardiomyopathy
Zhang, W., Xu, W., Feng, Y. Y., & Zhou, X. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14510 · Cited by 87
Tromp, J., Lim, S. L., Tay, W. T., Teng, T. K., Chandramouli, C., Ouwerkerk, W., Wander, G., Sawhney, J. P. S., Yap, J. J. L., MacDonald, M. R., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2515 · Cited by 87
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Mukhopadhyay, B., Patel, V., Haskó, G., Szabó, C., Mabley, J. G., Liaudet, L., & Pacher, P. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00564.x · Cited by 85
Connelly, K. A., Kelly, D. J., ZHANG, Y., Prior, D., Martin, J. H., COX, A., Thai, K., Feneley, M. P., Tsoporis, J. N., White, K., et al. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.022 · Cited by 85
Lu, Z., Jiang, Y., Xu, X., Ballou, L. M., Cohen, I. S., & Lin, R. Z. (2007) · Diabetes · doi:10.2337/db06-1629 · Cited by 84
Yang, X., Li, X. A., Lin, Q., & Xu, Q. (2019) · Gene · doi:10.1016/j.gene.2019.143995 · Cited by 84
Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease
Fu, T., Mohan, M., Brennan, E. P., Woodman, O. L., Godson, C., Kantharidis, P., Ritchie, R. H., & Qin, C. X. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00097 · Cited by 83
Self-citationBlasio, M. J. D., Huynh, K., Qin, C. X., Rosli, S., Kiriazis, H., Ayer, A., Cemerlang, N., Stocker, R., Du, X., McMullen, J. R., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.028 · Cited by 82
Self-citationO-GlcNAcylation in immunity and inflammation: An intricate system (Review)
Yu, L. S., Xie, M.-Z., Men, L., & Du, J. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4238 · Cited by 81
Vasanji, Z., Cantor, E. J. F., Juric, D., Moyen, M., & Netticadan, T. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00086.2005 · Cited by 80
Olson, A. K., Bouchard, B., Zhu, W. Z., Chatham, J. C., & Rosiers, C. D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010565 · Cited by 80
Vascularized cardiac spheroids as novel 3D in vitro models to study cardiac fibrosis
Figtree, G. A., Bubb, K. J., Tang, O., Kizana, E., & Gentile, C. (2017) · Cells Tissues Organs · doi:10.1159/000477436 · Cited by 79
Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy
Ge, Z., Lian, Q., Mao, X., & Xia, Z. (2019) · International Heart Journal · doi:10.1536/ihj.18-476 · Cited by 79
Davidoff, A. J., Davidson, M., Carmody, M. W., Davis, M.-E., & Ren, J. T. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000038231.68078.4b · Cited by 78
Desrois, M., Sidell, R. J., Gauguier, D., Davey, C. L., Radda, G. K., & Clarke, K. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.014 · Cited by 77
Mitochondrial quality control in the diabetic heart
Liang, Q., & Kobayashi, S. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.025 · Cited by 77
Targeting advanced glycation with pharmaceutical agents: where are we now?
Borg, D. J., & Forbes, J. M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9691-1 · Cited by 77
Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
Ritchie, R. H., Zerenturk, E. J., Prakoso, D., & Calkin, A. C. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0249 · Cited by 77
Self-citationThe role of NADPH oxidases in diabetic cardiomyopathy
Hansen, S. S., Aasum, E., & Hafstad, A. D. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.025 · Cited by 77
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ Damage
Elbatreek, M. H., Pachado, M. P., Cuadrado, A., Jandeleit-Dahm, K. A. M., & Schmidt, H. H. H. W. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.02.006 · Cited by 77
Axelsen, L. N., Lademann, J. B., Petersen, J. S., Holstein‐Rathlou, N., Ploug, T., Prats, C., Pedersen, H. D., & Kjølbye, A. L. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00392.2009 · Cited by 76
Qin, C. X., Sleaby, R., Davidoff, A. J., Bell, J. R., Blasio, M. J. D., Delbridge, L. M. D., Chatham, J. C., & Ritchie, R. H. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.016 · Cited by 76
Self-citationLipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
Brennan, E. P., Mohan, M., McClelland, A., Tikellis, C., Ziemann, M., Kaspi, A., Gray, S. P., Pickering, R. J., Tan, S. M., Shah, S. T. A., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017101112 · Cited by 76
Moir, S., Hanekom, L., Fang, Z.-Y., Haluska, B. A., Wong, C. Y., Burgess, M. I., & Marwick, T. H. (2006) · Heart · doi:10.1136/hrt.2005.079350 · Cited by 75
AcuteO-GlcNAcylation prevents inflammation-induced vascular dysfunction
Hilgers, R. H. P., Xing, D., Gong, K., Chen, Y.-F., Chatham, J. C., & Oparil, S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01175.2011 · Cited by 74
Spallotta, F., Cencioni, C., Atlante, S., Garella, D., Cocco, M., Mori, M., Mastrocola, R., Kuenne, C. T., Günther, S., Nanni, S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311300 · Cited by 74
Self-citationPapadaki, M., Holewinski, R. J., Previs, S. B., Martin, T. G., Stachowski, M. J., Li, A. S., Blair, C. A., Moravec, C. S., Eyk, J. E. V., Campbell, K. S., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121264 · Cited by 74
The Different Roles of miRNA-92a-2-5p and let-7b-5p in Mitochondrial Translation in db/db Mice
Li, H., Dai, B., Fan, J., Chen, C., Nie, X., Yin, Z., Zhao, Y., Zhang, X., & Wang, D. W. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.06.013 · Cited by 71
Genetic loss of insulin receptors worsens cardiac efficiency in diabetes
Bugger, H., Riehle, C., Jaishy, B. P., Wende, A. R., Tuinei, J., Chen, D., Soto, J. E., Pires, K. M. P., Boudina, S., Theobald, H. A., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.001 · Cited by 69
Self-citationRedox biology and the interface between bioenergetics, autophagy and circadian control of metabolism
Wende, A. R., Young, M. E., Chatham, J. C., Zhang, J., Rajasekaran, N. S., & Darley-Usmar, V. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.022 · Cited by 69
Prevalence and Prognostic Implications of Pre-Diabetic State in Patients With Heart Failure
Matsue, Y., Suzuki, M., Nakamura, R. A., Abe, M., Ono, M., Yoshida, S., Seya, M., Iwatsuka, R., Mizukami, A., Setoguchi, M., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0754 · Cited by 68
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes
Blasio, M. J. D., Huynh, N., Deo, M., Dubrana, L. E., Walsh, J. L., Willis, A. M., Prakoso, D., Kiriazis, H., Donner, D. G., Chatham, J. C., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00124 · Cited by 68
Self-citationTrapannone, R., Mariappa, D., Ferenbach, A. T., & van Aalten, D. M. F. (2016) · Biochemical Journal · doi:10.1042/bcj20160092 · Cited by 67
Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway
Li, X., Li, Z., Li, B., Zhu, X., & Lai, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116773 · Cited by 67
Liang, D., Zhong, P., Hu, J., Lin, F., Qian, Y., Xu, Z., Wang, J., Zeng, C., Li, X., & Liang, G. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.029 · Cited by 65
Amelioration of High Fructose-Induced Cardiac Hypertrophy by Naringin
Park, J. H., Ku, H. J., Kim, J. K., Park, J., & Lee, J. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-27788-1 · Cited by 65
FESC, F. E. O. A. D.-4. I. O. L. V. D. D. I. P. W. T. 2. D. A. D. C. (. S. I., Oe, H., Nakamura, K., Kihara, H., Shimada, K., Fukuda, S., Takagi, T., Miyoshi, T., Hirata, K., Yoshikawa, J., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0242-z · Cited by 64
Botta, A. M., Laher, I., Beam, J., DeCoffe, D., Brown, K., Halder, S., Devlin, A. M., Gibson, D. L., & Ghosh, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070248 · Cited by 64
Prakoso, D., Blasio, M. J. D., Qin, C. X., Rosli, S., Kiriazis, H., Qian, H., Du, X., Weeks, K. L., Gregorevic, P., McMullen, J. R., et al. (2017) · Clinical Science · doi:10.1042/cs20170063 · Cited by 64
Self-citationPal, P. B., Sonowal, H., Shukla, K., Sk, S., & Ramana, K. V. (2017) · Endocrinology · doi:10.1210/en.2017-00294 · Cited by 64
Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy
Tan, X., Hu, L., Shu, Z., Chen, L., Li, X., Du, M., Sun, D., Mao, X., Deng, S., Huang, K., et al. (2019) · Diabetes · doi:10.2337/db18-1231 · Cited by 64
Ritchie, R. H., Quinn, J. M. W., Cao, A., Drummond, G. R., Kaye, D. M., Favaloro, J. M., Proietto, J., & Delbridge, L. M. D. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.03.900 · Cited by 62
Self-citationNelson, V. L., Jiang, Y., Dickman, K. G., Ballou, L. M., & Lin, R. Z. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00625.2013 · Cited by 62
Chandramouli, C., Reichelt, M. E., Curl, C. L., Varma, U., Bienvenu, L. A., Koutsifeli, P., Raaijmakers, A. J. A., Blasio, M. J. D., Qin, C. X., Jenkins, A. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20703-8 · Cited by 62
Self-citationSodium–Glucose Cotransporter–2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes
Kramer, C. K., & Zinman, B. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-042017-094221 · Cited by 62
Chrysohoou, C. A., Pitsavos, C., Barbetseas, J. D., Kotroyiannis, I., Brili, S. V., Vasiliadou, K., Papadimitriou, L., & Stefanadis, C. (2009) · Heart and Vessels · doi:10.1007/s00380-008-1080-7 · Cited by 61
Hu, B. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.489 · Cited by 60
Yang, Y., Tsai, C.-Y., Chen, C.-L., Kuo, C., Hou, C., Cheng, S.-Y., Aneja, R., Huang, C., & Kuo, W. (2018) · Aging and Disease · doi:10.14336/ad.2017.0924 · Cited by 59
Enomoto, M., Ishizu, T., Seo, Y., Kameda, Y., Suzuki, H., Shimano, H., Kawakami, Y., & Aonuma, K. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.03.007 · Cited by 58
Post‐translational modifications of the cardiac proteome in diabetes and heart failure
Wende, A. R. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500052 · Cited by 57
Protein O-GlcNAcylation: A Critical Regulator of the Cellular Response to Stress
Chatham, J. C., & Marchase, R. B. (2010) · Current Signal Transduction Therapy · doi:10.2174/157436210790226492 · Cited by 55
Hayashi, T., Sohmiya, K., Ukimura, A., Endoh, S., Mori, T., Shimomura, H., Okabe, M., Terasaki, F., & Kitaura, Y. (2003) · Heart · doi:10.1136/heart.89.10.1236 · Cited by 53
Ng, H. H., Leo, C. H., Prakoso, D., Qin, C. X., Ritchie, R. H., & Parry, L. J. (2017) · Scientific Reports · doi:10.1038/srep39604 · Cited by 53
Self-citationPrakoso, D., Blasio, M. J. D., Tate, M., Kiriazis, H., Donner, D. G., Qian, H., Nash, D. M., Deo, M., Weeks, K. L., Parry, L. J., et al. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00632.2019 · Cited by 52
Self-citationSubclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives
León, L. E., Rani, S., Fernández, M., Larico, M., & Calligaris, S. D. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6143129 · Cited by 51
Echocardiographic feature of diabetic cardiomyopathy: where are we now?
Negishi, K. (2018) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.01.03 · Cited by 51
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
McMurray, J. J. V., Solomon, S. D., Docherty, K. F., & Jhund, P. S. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz916 · Cited by 49
Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy
Koga, K., Kenessey, Á., & Ojamaa, K. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00595.2012 · Cited by 47
Tate, M., Deo, M., Cao, A. H., Hood, S. G., Huynh, K., Kiriazis, H., Du, X., Julius, T. L., Figtree, G. A., Dusting, G. J., et al. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117710390 · Cited by 47
Self-citationRelation of Aortic Stiffness to Left Ventricular Remodeling in Younger Adults With Type 2 Diabetes
Gulsin, G. S., Swarbrick, D. J., Hunt, W., Levelt, E., Graham-Brown, M. P. M., Parke, K. S., Wormleighton, J. V., Lai, F. Y., Yates, T. E., Wilmot, E. G., et al. (2018) · Diabetes · doi:10.2337/db18-0112 · Cited by 47
Qin, C. X., Finlayson, S. B., Al‐Sharea, A., Tate, M., Blasio, M. J. D., Deo, M., Rosli, S., Prakoso, D., Thomas, C. J., Kiriazis, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16317-1 · Cited by 46
Self-citationWang, J., Wang, S., Wang, W., Chen, J., Zhang, Z., Zheng, Q., Liu, Q., & Cai, L. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14520 · Cited by 46
de Gaetano, M., McEvoy, C. M., Andrews, D. C., Cacace, A., Hunter, J., Brennan, E. P., & Godson, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01488 · Cited by 44
Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study
Lončarević, B., Trifunović, D., Soldatović, I., & Vujisic-Tesic, B. D. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0395-z · Cited by 43
Left Ventricular Diastolic Dysfunction in Type 2 Diabetes—Progress and Perspectives
Grigorescu, E.-D., Lăcătușu, C.-M., Floria, M., Mihai, B. M., Crețu, I., & Șorodoc, L. (2019) · Diagnostics · doi:10.3390/diagnostics9030121 · Cited by 43
Yu, Y., OHMORI, K., KONDO, I., Yao, L., NOMA, T., TSUJI, T., Mizushige, K., & KOHNO, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00513-8 · Cited by 42
Diastolic Heart Failure: Progress, Treatment Challenges, and Prevention
Wood, P., Piran, S., & Liu, P. P. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.02.008 · Cited by 42
Characterising an Alternative Murine Model of Diabetic Cardiomyopathy
Tate, M., Prakoso, D., Willis, A. M., Peng, C. Y., Deo, M., Qin, C. X., Walsh, J. L., Nash, D. M., Cohen, C. D., Rofe, A. K., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01395 · Cited by 42
Self-citationEchouffo-Tcheugui, J. B., Masoudi, F. A., Bao, H., Spatz, E. S., & Fonarow, G. C. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004132 · Cited by 41
Blasio, M. J. D., Ramalingam, A. R., Cao, A. H., Prakoso, D., Ye, J., Pickering, R. J., Watson, A. M. D., de Haan, J. B., Kaye, D. M., & Ritchie, R. H. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.04.026 · Cited by 41
Self-citationPires, K. M. P., Buffolo, M., Schaaf, C., Symons, J. D., Cox, J. E., Abel, E. D., Selzman, C. H., & Boudina, S. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.10.001 · Cited by 41
Self-citationA review of fibroblast growth factor 21 in diabetic cardiomyopathy
Zhang, X., Luo, Y., Xu, X., Tang, F., Yi, P., Qiu, B., & Hao, Y. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09809-x · Cited by 40
Increased TLR2 expression in patients with type 1 diabetes: evidenced risk of microalbuminuria
Ururahy, M. A. G., Loureiro, M. B., Freire‐Neto, F. P., de Souza, K. S. C., Zuhl, I., Brandão‐Neto, J., Hirata, R. D. C., Doi, S. Q., Arrais, R. F., Hirata, M. H., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00794.x · Cited by 39
Toyama, K., Nakamura, T., Kataoka, K., Yasuda, O., Fukuda, M., Tokutomi, Y., Dong, Y., Ogawa, H., & Kim‐Mitsuyama, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.012 · Cited by 37
Park, J., Jung, J., Yang, J., & Kim, H. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.07.011 · Cited by 36
Kahlberg, N., Qin, C. X., Anthonisz, J., Jap, E., Ng, H. H., Jelinic, M., Parry, L. J., Kemp‐Harper, B. K., Ritchie, R. H., & Leo, C. H. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.025 · Cited by 36
Self-citationVukomanovic, V., Suzic-Lazić, J., Celic, V. P., Cuspidi, C., Petrovic, T., Grassi, G. M., & Tadić, M. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002125 · Cited by 34
Guan, Y., Zhou, L., Zhang, Y., Tian, H., Li, A., & Han, X. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.06.004 · Cited by 34
Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db/db Mice
Horiguchi, C. S., Ogawa, D., Wada, J., Tachibana, H., Kodera, R., Eguchi, J., Nakatsuka, A., Terami, N., Shikata, K., & Makino, H. (2013) · Nephron Experimental Nephrology · doi:10.1159/000343102 · Cited by 33
Luo, W., Jin, Y., Wu, G., Zhu, W., Qian, Y., Zhang, Y., Li, J., Zhu, A., & Liang, G. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.03.005 · Cited by 32
Ng, A. C. T., Bertini, M., Ewe, S. H., van der Velde, E. T., Leung, D. Y., Delgado, V., & Bax, J. J. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.06.011 · Cited by 32
Janssens, J. V., Ma, B., Brimble, M. A., Eyk, J. E. V., Delbridge, L. M. D., & Mellor, K. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33886-x · Cited by 31
Phenotyping diabetic cardiomyopathy in Europeans and South Asians
Paiman, E. H. M., van Eyk, H. J., Bizino, M. B., Dekkers, I. A., de Heer, P., Smit, J. W. A., Jazet, I. M., & Lamb, H. J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0940-z · Cited by 31
Jensen, M. T., Søgaard, P., Gustafsson, I., Bech, J. W., Hansen, T. F., Almdal, T., Theilade, S., Biering‐Sørensen, T., Jørgensen, P. G., Galatius, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05009-2 · Cited by 31
Hypertension and Diabetes—A Toxic Combination
Bell, D. S. H. (2008) · Endocrine Practice · doi:10.4158/ep.14.8.1031 · Cited by 30
Ruiz, M., Coderre, L., Lachance, D., Houde, V., Martel, C., Legault, J. T., Gillis, M., Bouchard, B., Daneault, C., Carpentier, A. C., et al. (2015) · Diabetes · doi:10.2337/db15-0238 · Cited by 29
Solheim, M. H., Winnay, J. N., Batista, T. M., Molven, A., Njølstad, P. R., & Kahn, C. R. (2018) · Diabetes · doi:10.2337/db17-1509 · Cited by 29
Xu, Y.-Z., Zhang, X., Wang, L., Zhang, F., Qiu, Q., Liu, M., Zhang, G., & Wu, X. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.8839 · Cited by 28
Earlier onset of diabesity‐Induced adverse cardiac remodeling in female compared to male mice
Bowden, M. A., Tesch, G. H., Julius, T. L., Rosli, S., Love, J. E., & Ritchie, R. H. (2015) · Obesity · doi:10.1002/oby.21072 · Cited by 28
Self-citationDiabetic cardiac autonomic neuropathy: Insights from animal models
Stables, C. L., Glasser, R., & Feldman, E. L. (2013) · Autonomic Neuroscience · doi:10.1016/j.autneu.2013.03.001 · Cited by 25
Cao, N., Wong, Y. G., Rosli, S., Kiriazis, H., Huynh, K., Qin, C. X., Du, X., Kemp‐Harper, B. K., & Ritchie, R. H. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001699 · Cited by 24
Self-citationMeCP2 triggers diabetic cardiomyopathy and cardiac fibroblast proliferation by inhibiting RASSF1A
Tao, H., Tao, J., Song, Z., Shi, P., Wang, Q., Deng, Z.-Y., & Ding, X. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109387 · Cited by 24
Pouwels, M.-J. J., Span, P. N., Tack, C. J., Olthaar, A. J., Sweep, F. C. G. J., van Engelen, B. G. M., de Jong, J. G. N., Lutterman, J. A., & Hermus, A. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020440 · Cited by 22
Sultan, A. M., Singh, J., & Howarth, F. C. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09872-4 · Cited by 22
Joshi, M. S., Berger, P. J., Kaye, D. M., Pearson, J. T., Bauer, J. A., & Ritchie, R. H. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12070 · Cited by 21
Self-citationRole of angiotensin receptor blockers in diabetes: implications of recent clinical trials
McFarlane, S. I. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.115 · Cited by 19
A morphological quantitative study of small vessels in diabetic cardiomyopathy.
Gherasim, L., Taşcă, C., Havriliuc, C., & Vasilescu, C. (1985) · PubMed · Cited by 17
Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes
Tare, M., Kalidindi, R. S. R., Bubb, K. J., Parkington, H. C., Boon, W., Li, X., Sobey, C. G., Drummond, G. R., Ritchie, R. H., & Kemp‐Harper, B. K. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1336-1 · Cited by 17
Self-citationDifferential hexosamine biosynthetic pathway gene expression with type 2 diabetes
Coomer, M. A., & Essop, M. F. (2014) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.03.003 · Cited by 16
Xiao, Q., Yang, Y., Zhao, X., He, L., Qin, Y. H., He, Y., Zhang, G., & Luo, J. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2766 · Cited by 15
Lassen, M. C. H., Jensen, M. T., Biering‐Sørensen, T., Møgelvang, R., Fritz‐Hansen, T., Vilsbøll, T., Rossing, P. R., & Jørgensen, P. G. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez075 · Cited by 15
Lam, B., Stromp, T. A., Hui, Z., & Vandsburger, M. H. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.05.029 · Cited by 15
Pires, K. M. P., Torres, N. S., Buffolo, M., Gunville, R., Schaaf, C., Davis, K., Selzman, C. H., Gottlieb, R. A., & Boudina, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7640 · Cited by 14
Mizuno, R., Fujimoto, S., Saito, Y., & Nakamura, S. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.10.024 · Cited by 11
Cardiovascular outcome trials of diabetes drugs: lessons learned
Taylor, S. I., & Leslie, B. R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99820 · Cited by 11
Epigenetic role of micrornas in diabetic cardiomyopathy
Khullar, M., Raut, S. K., & Kumar, A. (2016) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/2395-5414.191519 · Cited by 4
Cited by
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Self-citationDiabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Self-citationYang, D.-R., Wang, M.-Y., Zhang, C.-L., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359255 · Cited by 280
Nakamura, K., Miyoshi, T., Yoshida, M., Akagi, S., Saito, Y., Ejiri, K., Matsuo, N., Ichikawa, K., Iwasaki, K., Naito, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073587 · Cited by 268
The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF
Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74
Metadata
- Authors
- Ritchie, R. H., & Abel, E. D.
- Venue
- Circulation Research
- Published
- 2020-05-22
- Volume
- 126
- Issue
- 11
- Pages
- 1501-1525
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W3026907472
- Cited by
- 708
- References
- 369
- FWCI
- 38.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.